/ Not yet recruitingPhase 4 A multi centric single arm open label phase 4 clinical study to evaluate the safety and tolerability of Povidone Iodine Alcoholic Prep10 percentage W by V Betadine for the disinfection of the skin prior to invasive surgical procedures
A Phase-3 multi centre, randomized, parallel, double blind, placebo control, clinical study to determine the efficacy and safety of Betadine Nasal spray Povidone Iodine IP 0.5% w/v for the treatment of Rhinitis in patients suffering from Rhinitis associated with Upper respiratory tract infection along with standard care of therapy. - NIL
100 Clinical Results associated with G S Pharmbutor Pvt Ltd.
0 Patents (Medical) associated with G S Pharmbutor Pvt Ltd.
100 Deals associated with G S Pharmbutor Pvt Ltd.
100 Translational Medicine associated with G S Pharmbutor Pvt Ltd.